Century Therapeutics, Inc. (IPSC) › Shareholders' EquityCentury Therapeutics, Inc. (IPSC) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2019: -$91.86M2020: -$106.41M2021: $396.24M2022: $302.74M2023: $184.75M2024: $161.36M2025: $158.94M$158.94M2019Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$158.94M-1.5%2024$161.36M-12.7%2023$184.75M-39.0%2022$302.74M-23.6%2021$396.24M+472.4%2020-$106.41M-15.8%2019-$91.86M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share